Discover 2,427 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,427
NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors
for
Very Rare Tumors, Very Rare Cancers, Other Solid Tumors,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 70+
Code: NCT07489378
Recruiting
Turner Syndrome: Genetic Considerations
for
Genetic
Location: Bethesda MD
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Sex: All
Age: 0 - 70+
Code: NCT07502586
Recruiting
DDAVP for Pituitary Adenoma
for
Cushing's Disease, Pituitary Adenoma
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Sex: All
Age: 8 - 70+
Code: NCT04569591
Recruiting
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
for
Kaposi Sarcoma
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT07308886
Phase 2, Recruiting
A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
for
Neurofibromatosis Type 1
Location: Bethesda MD, Washington D.C. DC
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 70+
Code: NCT06507748
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
for
Adenocarcinoma of the Bladder,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06041503
Phase 2, Recruiting
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
for
Sjogren's Syndrome
Location: Bethesda MD
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Sex: All
Age: 18 - 70+
Code: NCT07281456
Phase 2, Recruiting
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
for
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT07667400
Phase 1, Phase 2, Recruiting
Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 2 - 70+
Code: NCT07202598
Phase 2, Recruiting
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
for
Hematologic Malignancies, Hematologic Neoplasms
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT07162038
Phase 1, Recruiting
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
for
Breast Cancer, Breast Carcinoma, Cancer of the Breast,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT07619534
Recruiting
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
B-All, Acute Lymphoblastic Leukemia
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT07572136
Phase 1, Recruiting
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
for
Breast Cancer, Breast Carcinoma, Cancer of the Breast,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT07067138
Recruiting
Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research
for
Endothelial Dysfunction,
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)
Sex: All
Age: 18 - 70+
Code: NCT03253705
Recruiting
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy
for
Human Immunodeficiency Virus
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT06819176
Phase 1, Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
for
Untreated Follicular Lymphoma
Location: Bethesda MD, New York NY, New Haven CT, Albany NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06549595
Phase 3, Recruiting
Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections
for
Aspergillos, Mucormye, Dimorphic, Other Molds, Non-Aspergillos,
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)
Sex: All
Age: 18 - 70+
Code: NCT07704333
Phase 1, Recruiting
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
for
Allogeneic Stem Cell Transplantation,
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 18 - 70+
Code: NCT07613099
Phase 3, Recruiting
PET Imaging of Noradrenergic Transmission in the Brain
for
Healthy
Location: Bethesda MD
Sponsor: National Institute of Mental Health (NIMH)